Abbott Laboratories

NYSE:ABTHealthcareCBOE:SPESGSTOXX:EDD24BP

$103.39−0.64%LiveIn session · ≈ AED 379.70 · Market cap $180.09B · Next earnings Wed 21 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	50.2%	53.9%	51.1%	50.0%	50.8%	55.5%	—	—
Operating margin	15.3%	21.4%	19.2%	16.0%	16.3%	18.2%	18.2%	+0.0 pts
Net margin	13.0%	16.4%	15.9%	14.3%	31.9%	14.7%	14.7%	+0.0 pts
EBITDA margin	26.0%	28.2%	27.2%	26.4%	25.8%	26.1%	—	—
Return on equity	13.7%	19.8%	18.9%	14.8%	28.1%	12.5%	12.4%	−0.2 pts
Return on assets	6.2%	9.4%	9.3%	7.8%	16.5%	7.5%	7.5%	+0.0 pts
Return on capital employed	8.7%	14.8%	14.2%	10.8%	10.1%	11.5%	—	—
Debt / equity	0.6×	0.5×	0.5×	0.4×	0.3×	0.3×	0.3×	−1.2%
Debt / assets	27.4%	25.6%	24.1%	21.7%	18.8%	17.4%	—	—
Interest coverage	7.5×	22.4×	26.5×	9.2×	11.3×	23.6×	—	—
Current ratio	1.7×	1.8×	1.6×	1.6×	1.7×	1.6×	1.6×	+0.0%
Quick ratio	1.3×	1.5×	1.2×	1.2×	1.2×	1.2×	—	—
Cash ratio	0.6×	0.7×	0.6×	0.5×	0.5×	0.5×	0.5×	+0.0%
Asset turnover	0.5×	0.6×	0.6×	0.5×	0.5×	0.5×	—	—
Inventory turnover	3.4×	3.9×	3.5×	3.1×	3.3×	3.0×	—	—
Receivables turnover	5.4×	6.6×	7.0×	6.1×	6.1×	5.6×	—	—
Dividend payout	57.0%	45.3%	47.7%	62.1%	28.6%	63.1%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.